Real-world effectiveness of perinatal RSV immunoprophylaxis: protocol for a test-negative case–control study
Llorente C, Wats A, Araujo B, Ganem J, Oliva I, Xu H, Brodsky N, Lucas C, Aronson P, Grubaugh N, Breban M, Redmond S, Shapiro E, Niccolai L, Weinberger D, Oliveira C. Real-world effectiveness of perinatal RSV immunoprophylaxis: protocol for a test-negative case–control study. BMJ Open 2026, 16: e114524. PMID: 41856594, PMCID: PMC13007147, DOI: 10.1136/bmjopen-2025-114524.Peer-Reviewed Original Research
ConceptsRespiratory syncytial virusAcute respiratory illnessTest-negative case-control studyCase-control studyLong-acting monoclonal antibodiesSingle-cell immune profilingRSV-negative infantsImmune-escape mutationsConvalescent blood samplesRSV-positive specimensPrelicensure clinical trialsMultivariate logistic regressionWritten Informed ConsentHuman Investigation CommitteeMaternal vaccinationState immunization registryImmune profileBreakthrough infectionSyncytial virusClinical trialsNational InstituteVaccine effectivenessPotential confoundersControlled TrialsInfants